Related Experiment Video
Updated: Dec 31, 2025

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Focal adhesion protein Kindlin-2 regulates bone homeostasis in mice
Huiling Cao1, Qinnan Yan1, Dong Wang2
11Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research, Shenzhen Key Laboratory of Cell Microenvironment, and Department of Biology, Southern University of Science and Technology, Shenzhen, 518055 China.
Abstract:
Our recent studies demonstrate that the focal adhesion protein Kindlin-2 is critical for chondrogenesis and early skeletal development. Here, we show that deleting Kindlin-2 from osteoblasts using the 2.3-kb mouse Col1a1-Cre transgene minimally impacts bone mass in mice, but deleting Kindlin-2 using the 10-kb mouse Dmp1-Cre transgene, which targets osteocytes and mature osteoblasts, results in striking osteopenia in mice. Kindlin-2 loss reduces the osteoblastic population but increases the osteoclastic and adipocytic populations in the bone microenvironment. Kindlin-2 loss upregulates sclerostin in osteocytes, downregulates β-catenin in osteoblasts, and inhibits osteoblast formation and differentiation in vitro and in vivo. Upregulation of β-catenin in the mutant cells reverses the osteopenia induced by Kindlin-2 deficiency. Kindlin-2 loss additionally increases the expression of RANKL in osteocytes and increases osteoclast formation and bone resorption. Kindlin-2 deletion in osteocytes promotes osteoclast formation in osteocyte/bone marrow monocyte cocultures, which is significantly blocked by an anti-RANKL-neutralizing antibody. Finally, Kindlin-2 loss increases osteocyte apoptosis and impairs osteocyte spreading and dendrite formation. Thus, we demonstrate an important role of Kindlin-2 in the regulation of bone homeostasis and provide a potential target for the treatment of metabolic bone diseases.
Insights
Kindlin-2 deletion in osteocytes causes osteopenia by increasing bone resorption and decreasing bone formation. Restoring beta-catenin reverses these effects, highlighting Kindlin-2 as a therapeutic target for bone diseases.
Area of Science:
- Bone Biology
- Skeletal Development
- Cell Adhesion Proteins
Background:
- Kindlin-2 is crucial for chondrogenesis and skeletal development.
- Specific Cre-lox systems are used to investigate Kindlin-2's role in distinct bone cell populations.
Purpose of the Study:
- To elucidate the specific role of Kindlin-2 in osteocytes and mature osteoblasts in maintaining bone homeostasis.
- To identify the molecular mechanisms by which Kindlin-2 deficiency impacts bone metabolism.
Main Methods:
- Utilized 10-kb mouse Dmp1-Cre transgene to delete Kindlin-2 in osteocytes and mature osteoblasts.
- Analyzed bone mass, cellular populations (osteoblasts, osteoclasts, adipocytes), and expression of key bone regulatory proteins (sclerostin, β-catenin, RANKL).
- Performed in vitro and in vivo studies, including co-culture assays and rescue experiments by β-catenin upregulation.
Main Results:
- Kindlin-2 deletion in osteocytes led to severe osteopenia.
- This resulted in reduced osteoblasts, increased osteoclasts and adipocytes, and elevated sclerostin and RANKL.
- Kindlin-2 loss impaired osteoblast differentiation, increased osteoclastogenesis, and induced osteocyte apoptosis and morphological changes.
- Upregulation of β-catenin rescued the osteopenic phenotype.
Conclusions:
- Kindlin-2 plays a critical role in regulating bone homeostasis, specifically within osteocytes.
- Kindlin-2 deficiency disrupts the balance between bone formation and resorption through modulation of sclerostin, β-catenin, and RANKL.
- Kindlin-2 represents a potential therapeutic target for metabolic bone diseases like osteoporosis.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Skeleton and Calcium Homeostasis
Intracellular Signaling Affects Focal Adhesions
Some...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...

